Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome Using Myo-Inositol

The document discusses a study involving 200 women with Polycystic Ovary Syndrome (PCOS) treated with a myo-inositol-based treatment, ProFecund Ino, over 24 months. The treatment resulted in a 38% pregnancy rate, with additional pregnancies achieved through further treatment and IVF procedures, leading to a total of 85% of participants achieving pregnancy. The treatment also improved hormonal balance, regulated menstrual cycles, stimulated ovulation, enhanced insulin sensitivity, and had positive effects on the nervous system. The study concluded that myo-inositol-based treatments, in conjunction with assisted reproductive techniques, significantly increase pregnancy chances for women with PCOS.